Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Pucotenlimab by Lepu Biopharma for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
Pucotenlimab is under clinical development by Lepu Biopharma and currently in Phase II for Head And Neck Squamous Cell Carcinoma...
Data Insights
Pucotenlimab by Lepu Biopharma for Nasopharyngeal Cancer: Likelihood of Approval
Pucotenlimab is under clinical development by Lepu Biopharma and currently in Phase II for Nasopharyngeal Cancer. According to GlobalData, Phase...